Webinar Overview

Bispecific antibodies represent a rapidly expanding class of biotherapeutics, presenting distinct innovation trends across multiple fields including molecular engineering, process development, large scale manufacturing, and commercialization. However, the production process faces many bottlenecks: the tendency of aggregation of the molecules, the difficulty in removing product-related impurities, the stringent requirements for process compatibility.

This presentation will dive into the cutting-edge expertise and enabling technologies designed to streamline and integrate the full downstream purification workflow, while simultaneously boosting overall process efficiency, batch-to-batch consistency, and end-product quality profiles.

Key Learning Objectives

1. The value and prospects of bispecific antibodies

2. Challenges in downstream process development and large-scale production

3. Case study and strategies for asymmetric bispecific antibody

4. Strategies for viral clearance studies

Speaker 

Puya Zhao

Senior Director, Downstream process development, AsymBio